Cyclic dinucleotides (CDNs) play central roles in bacterial pathogenesis and innate immunity. The mammalian enzyme cGAS synthesizes a unique cyclic dinucleotide (cGAMP) containing a 2ʹ-5ʹ phosphodiester linkage essential for optimal immune stimulation, but the molecular basis for linkage specificity is unknown. Here, we show that the Vibrio cholerae pathogenicity factor DncV is a prokaryotic cGAS-like enzyme whose activity provides a mechanistic rationale for the unique ability of cGAS to produce 2ʹ-5ʹ cGAMP. Three high-resolution crystal structures show that DncV and human cGAS generate CDNs in sequential reactions that proceed in opposing directions. We explain 2ʹ and 3ʹ linkage specificity and test this model by reprogramming the human cGAS active site to produce 3ʹ-5ʹ cGAMP, leading to selective stimulation of alternative STING adaptor alleles in cells. These results demonstrate mechanistic homology between bacterial signaling and mammalian innate immunity and explain how active site configuration controls linkage chemistry for pathway-specific signaling.
INTRODUCTION
Cyclic dinucleotides (CDNs) are key regulators of both bacterial physiology and mammalian innate immunity (Cai et al., 2014; Danilchanka and Mekalanos, 2013) . Cyclic di-guanosine monophosphate (cdG) was originally discovered as a smallmolecule regulator of cellulose production in Acetobacter (Ross et al., 1987) , but it is now appreciated that cdG and cyclic di-adenosine monophosphate (cdA) regulate diverse processes, including biofilm formation, antibiotic signaling, and the bacterial stress response (Danilchanka and Mekalanos, 2013) . In addition, cdG regulates developmental pathways in the eukaryote Dictyostelium (Chen and Schaap, 2012) . More recently, a mixed base cyclic GMP-AMP molecule (cGAMP) was discovered in Vibrio cholerae seventh pandemic strains, and the responsible synthase, DncV, was identified as a virulence factor on pandemic island-1 (Davies et al., 2012) . Remarkably, cyclic GMP-AMP was discovered shortly thereafter as the eukaryotic signal responsible for triggering innate immune responses downstream of cytosolic DNA recognition in mammalian cells , and the human enzyme cyclic GMP-AMP synthase (cGAS) is a major sensor for DNA-triggered innate immunity (Li et al., 2013b; Schoggins et al., 2014) . Despite the prevalence of cyclic dinucleotide signaling in both prokaryotic and eukaryotic kingdoms of life, it remains to be proven whether a direct connection exists between the signaling machinery that produces or responds to dinucleotides in either kingdom.
The bacterial cyclic dinucleotide synthases investigated to date function as obligate oligomers in which each active site in adjacent monomers generates one of the two phosphodiester bonds necessary to produce the final symmetric cyclized product (Chan et al., 2004; De et al., 2008; Witte et al., 2008) . By contrast, the mammalian cGAS enzyme functions with a single active site, using a sequential series of reactions to produce a mixed dinucleotide species G[2ʹ-5ʹ]pA[3ʹ-5ʹ]p (cGAMP) containing a 2ʹ-5ʹ phosphodiester bond Diner et al., 2013; Gao et al., 2013a; Zhang et al., 2013) . The unique 2ʹ-5ʹ linkage in cGAMP has been shown to be responsible for enhanced immunity through increased stimulation of the adaptor STING (Diner et al., 2013; Gao et al., 2013b; Zhang et al., 2013) , but potential additional roles for the 2ʹ-5ʹ cGAMP linkage in stability or signal discrimination remain unknown.
The requirement for a mixed dinucleotide potentially drove evolution of human cGAS to rely on a single active site and sequential enzymatic reactions. However, the prokaryotic Vibrio DncV enzyme also produces a mixed-base 3ʹ-5ʹ cGAMP molecule Davies et al., 2012; Diner et al., 2013) . Vibrio DncV has been hypothesized to function similarly to cGAS (Diner et al., 2013; Gao et al., 2013a) , but the low sequence homology (<10%) between DncV and mammalian OAS/cGAS family enzymes precludes prediction about whether DncV's mechanism of action is functionally similar to cGAS or to conventional oligomeric bacterial dinucleotide cyclases. We reasoned that investigation of the molecular mechanism of Vibrio DncV would reveal how enzymes that synthesize mixed cyclic dinucleotides evolved in the prokaryotic kingdom. Such insights could in turn provide a new framework to understand the distinct ability of human cGAS to catalyze the 2ʹ-5ʹ linkage specificity that is critical to innate immune signaling.
Here, we present a series of structures of Vibrio cholerae DncV, capturing the enzyme in substrate bound and catalytically trapped linear-intermediate states. In spite of the minimal sequence identity, our results show that DncV is both a structural and functional homolog of mammalian cGAS, demonstrating for the first time a direct connection between the biosynthetic machinery for generating dinucleotide signals in multiple kingdoms of life. Although the active site shares a common architecture between DncV and cGAS, we establish that the sequential enzymatic reactions proceed in opposite directions, with DncV using a 5ʹ pppA [3ʹ-5ʹ]pG intermediate and cGAS a 5ʹ pppG[2ʹ-5ʹ]pA intermediate. By comparing the two enzymes, we derive a model that explains how single active site cyclases control phosphodiester linkage specificity and how human cGAS rotates the substrate nucleotides to produce the 2ʹ-5ʹ linkage unique to mammalian innate immunity. This model allowed us to rationally redesign the human cGAS active site for production of enzymatic variants that now synthesize 3ʹ-5ʹ linked species. These results provide an evolutionary connection between prokaryotic and eukaryotic signaling systems and elucidate enzymatic plasticity that allowed evolution of a unique metazoan innate immune molecule.
RESULTS AND DISCUSSION

Structure of Vibrio cholerae DncV Reveals an Autoactivated cGAS-like Enzyme
We isolated a near-full-length construct of Vibrio cholerae DncV (M4-L414) that retains full enzymatic activity and determined its 3.0 Å resolution crystal structure. Selenomethionine derivatized crystals were used for phase determination, and model refinement was additionally improved by a higher-resolution catalytically trapped intermediate structure (discussed below; Table S1 available online). The core of DncV adopts a template-independent nucleotidyl-transferase fold defined by b strands b2-5, similar to the originally characterized CCA-adding enzyme (Figure 1 ) (Xiong and Steitz, 2004) . In spite of minimal sequence identity ($10%), the overall structure of DncV is remarkably similar to that of human cGAS (Figures 1B and S1) (Kato et al., 2013; Kranzusch et al., 2013; Li et al., 2013a; Zhang et al., 2014) . In addition, the catalytic core of DncV is nearly as structurally conserved as the previously described relationship between cGAS and the double-stranded RNA (dsRNA)-sensor oligo-adenylate synthase (OAS) (root-mean-square deviation [RMSD] $3.8 Å versus $3.0 Å ) (Civril et al., 2013; Donovan et al., 2013; Kranzusch et al., 2013) .
The structure of Vibrio DncV reveals an autoactivated state, explaining why DncV is constitutively active, whereas cGAS requires stimulation by dsDNA binding. Although the overall fold of the core active site is shared, two unique features maintain constitutive activity of DncV. First, whereas dsDNA binding is required to configure the cGAS active site for competent metal ion coordination (Civril et al., 2013; Gao et al., 2013a) , in DncV, a-helical lobes brace either side of the active site and buttress b strands b2-5 to automatically position D132, D134, and D194 for divalent ion binding ( Figure 1A ). In agreement with automatic positioning, the orientations of DncV D132, D134, and D194 do not change between our apo and substrate bound or catalytically trapped structures (discussed below). Second, regulatory loops that restrict the substrate channel of cGAS (Gao et al., 2013a) are missing in the DncV enzyme, resulting in an open active site permanently competent for substrate binding ( Figures 1B, 1C , and S1). Recent structural studies have suggested that complete activation of cGAS requires protein dimerization (Li et al., 2013a; Zhang et al., 2014) . We noted that purified DncV behaves as a monomeric species, and there is no indication of functional dimerization within or between neighboring asymmetric units of the crystals ( Figure S2 ). In addition to remodeling that maintains an open and competent active site, these results demonstrate that DncV lacks regulatory dimerization contacts observed in eukaryotic cGAS and conventional bacterial dinucleotide cyclases (De et al., 2008; Li et al., 2013a; Witte et al., 2008; Zhang et al., 2014) .
DncV does not require dsDNA binding to stimulate enzymatic activity, and we therefore expected the basic DNA recognition cleft found in cGAS to be absent. Strikingly, however, DncV retains a long basic cleft with conserved residues along the same face of the enzyme ( Figures 1D and S1 ). Superposition of the mouse cGAS-DNA-bound structure immediately positions the dsDNA along this cleft without a need for manual docking ( Figure 1D ). We therefore tested the impact of DNA and RNA on DncV activity but saw no change in enzymatic behavior or mobility of DncV in electrophoretic gel-shift assays ( Figure S3 ). The possible role of this cleft in DncV biology and Vibrio pathogenicity remains an ongoing area of investigation.
DncV GTP Recognition Parallels cGAS Substrate Discrimination
We next compared the nucleotide substrate preferences of Vibrio DncV and human cGAS enzymes. As expected, enhanced product formation for each enzyme was observed in the presence of ATP and GTP ( Figure 2A) . We confirmed previous studies (Davies et al., 2012; Diner et al., 2013) that, when provided only ATP or only GTP, DncV synthesizes cdA and cdG ( Figure 2A) . Promiscuity of the active site for nucleotide selection is shared with human cGAS, which also inefficiently synthesizes both cdA and cdG species when presented with ATP or GTP alone ( Figure 2A ). Previous results with purified mouse cGAS were unable to detect cdA formation (Gao et al., 2013a) . Low levels of human cGAS cdA formation may therefore indicate further differences between the human and mouse homologs in addition to variation in dependency of DNA-stimulated activation requirements (Kranzusch et al., 2013; Sun et al., 2013) .
To ascertain the molecular basis of initial substrate selection, we determined the crystal structure of DncV bound to a nonhydrolyzable nucleotide in which a methylene bridge replaces the ɑ/b bridging oxygen (Apcpp or Gpcpp). The first step in cGAS product formation involves coordination of the adenosine triphosphate for 2ʹ hydroxyl attack by the guanosine ribose (Gao et al., 2013a) , but our initial crystallization attempts using an ATP analog failed to reveal difference density compared to the apo DncV structure. We therefore used the GTP analog and, in this case, obtained crystals with strong difference density for nucleotide, allowing us to determine the structure of DncV bound to Gpcpp analog at 2.8 Å resolution ( Figure 2B ). The bound GTP analog adopts an anti base configuration and follows a similar path to the adenosine nucleotide residing in the phosphate-donor pocket observed in the catalytically inactive structure of the pig cGAS (E200Q/D202N) enzyme ( Figure 2C ) (Civril et al., 2013) . GTP is coordinated by base-specific hydrogenbonding interactions between amino acid D349 and the guanine N1 and N2 positions along the Watson-Crick edge, whereas bridging interactions between two bound divalent cations connect the triphosphate moiety and the conserved DncV catalytic triad D132, D134, and D194 ( Figures 2D-2G ). DncV crystallization conditions require high magnesium concentrations, and the observed octahedral geometry of the bound metal ions (as seen in our higher-resolution 1.8 Å catalytically trapped structure) is consistent with magnesium ion coordination (Figures 2E and 2F) . In contrast to structures of cGAS, the base stacking interaction between human cGAS Y436 and bound nucleotides is notably absent in DncV. Instead, the tyrosine residue is replaced by I303 that retains active site pocket hydrophobicity but prevents stabilization of particular base orientation ( Figures  2D and 2G ).
Prokaryotic and Metazoan Dinucleotide Cyclization Reactions Proceed in Opposing Directions
We next crystallized DncV in the presence of combinations of ATP/GTP and nonhydrolyzable Apcpp/Gpcpp analogs. Difference density was obtained for crystals of DncV with GTP and Apcpp, and we determined the 1.8 Å resolution structure of this complex ( Figure 3A) . Unexpectedly, the electron density can clearly be traced for unambiguous assignment of a bound linear dinucleotide intermediate pp(c)pA[3ʹ-5ʹ]pG, implying that the first step in DncV nucleotide cyclization occurs through adenosine 3ʹ hydroxyl attack of the guanosine a-phosphate ( Figure 3B ). In this structure, the guanine and adenine bases adopt anti and syn base configurations, respectively. This observation suggests that the DncV reaction proceeds through a pppA(syn)[3ʹ-5ʹ]pG(anti) state similar to the mouse cGAS pppG(syn)[2ʹ-5ʹ]pG(anti) structure, where the second nucleotide to be hydrolyzed must pass through a syn conformation en route to product cyclization (Gao et al., 2013a) .
Hydrogen bonding interactions occur between Q113 and the guanosine 2ʹ OH, and bridging water interactions between T180 and I303/S302 backbone amines coordinate the guanosine and adenosine riboses, respectively ( Figure 3C ). Interactions with S115 and Y118, as well as the bridging metal B interactions, stabilize the adenosine triphosphate, and in the linear intermediate state, bridging interactions with metal A further stabilize the connecting A[3ʹ-5ʹ]pG phosphate ( Figure 3C ). The only interactions with the nucleotide bases occur through the guanine position where S260 and Y198 make contacts with the Watson-Crick edge and Y198 and Q113 contact the Hoogsteen edge ( Figure 3C ).
We next used combinations of a-radiolabeled substrates and nonhydrolyzable nucleotides to test the order of DncV-catalyzed reactions leading to cGAMP formation. Robust DncV linear dinucleotide product formation occurred in reactions containing 
Active Site Remodeling Controls Substrate Rotation and Phosphodiester Linkage Specificity
To understand mechanistic control of phosphodiester linkage specificity by cGAS-like enzymes, we compared the active site positioning of our DncV trapped linear intermediate structure (Figure 3) with that of the analogous mouse cGAS pppG[2ʹ-5ʹ] pG structure (Gao et al., 2013a) . Each dinucleotide is oriented by similar base and phosphate backbone interactions ( Figures  4A-4D ), but superposition of the two bound ligands reveals significant rotation of the dinucleotide base and ribose geometries with respect to each other. In DncV, the bases are rocked upward $40 away from the catalytic triad, which is consistent with repositioning of the 3ʹ or 2ʹ hydroxyl during the first phosphodiester bond formation ( Figure 4E ). Intriguingly, conserved residues in either enzyme would be predicted to clash with the alternative nucleotide orientations, indicating that each enzymatic pocket is specifically tailored to accept only one set of base rotation conformations.
An extended side chain (Q113) at the bottom of the pocket (site 1) and recessed side chain (I258) at the top of the pocket (site 2) support the upward rotation of the bases in the DncV active site. Conversely, a recessed side-chain T211 at site 1 below and an extended R376 side chain at site 2 above the bases induce the downward rotation of the bases in the cGAS active site ( Figures 4C, 4D , and 4E). The amino acids at sites 1 and 2 within the active site pocket share conserved combinations of recessed or extended combinations of side chains, such that, in general, prokaryotic DncV-like sequences encode an extended amino acid in the site 1 position, whereas eukaryotic cGAS-like sequences encode an extended amino acid in site 2 (Figures 4F and 4G and Table S2 ). An additional discriminating characteristic is a conserved Y436 amino acid found in all metazoan cGAS enzymes, where Y436 stacks with the bases on the opposite side of the pocket (site 3); prokaryotic sequences favor nonpolar residues incapable of base-stacking interactions in site 3 ( Figures 4C-4G and Table S2 ). These differences indicate that the location of extended amino acids in alternate site 1 or site 2 positions, with a possible stabilizing role for base-stacking interactions in site 3, direct rotation of the nucleotide bases to favor 3ʹ-5ʹ or 2ʹ-5ʹ linkage specificity.
Rational Reprogramming of Human cGAS Product Formation
This proposed model of linkage specificity arising from our structures suggested that it may be possible to exchange recessed and extended amino acid side chains at sites 1 through 3 to re-engineer the catalytic activity of human cGAS. We therefore replaced human cGAS site 1, 2, and 3 residues with the corresponding prokaryotic DncV amino acids and purified seven MBP-tagged mutant enzymes bearing single, double, or triple amino acid replacements to test for potentially altered catalytic activity. We found that human cGAS R376I and T211Q/R376I variant enzymes exhibit a significant change in dinucleotide product migration as observed by thin layer chromatography, implying altered product linkage specificity compared to the wild-type (WT) G[2ʹ-5ʹ]pA[3ʹ-5ʹ]p enzyme product ( Figure 5A ). Moreover, the mutant enzymes produce a dinucleotide species that migrates similarly to the DncV 3ʹ-5ʹ cyclic dinucleotide species. The human cGAS site 2 mutation R376I is most critical for altered specificity, but the compensatory extended mutation of T211Q in site 1 appears to increase enzymatic signaling potential in a cellular context. Notably, alterations to this position are not tolerated in the prokaryotic DncV enzyme (discussed below). Conversely, the human cGAS site 3 Y436I mutation does not impact product migration, and addition of the site 3 mutation Y436I to create a triple mutant disrupts enzymatic activity, which may result from too large of an increase of the active site pocket or loss of base-stacking explicitly required for the altered activity of the cGAS mutant enzymes ( Figure 5A ). In addition to binding pocket restrictions impacting rotation of the substrate nucleotides (Figure 4) , the cGAS site 2 R376I mutation may also relax guanine-specific base interactions to allow altered product specificity. In each of our substrate-bound structures of DncV, nucleotide-specific interactions occur primarily with the guanine base (Figures 2 and 3) . Contacts are made primarily through the guanine in the bound cGAS structures (Civril et al., 2013; Gao et al., 2013a) , indicating that, regardless of the opposing sequential order of reactions, DncV and cGAS are naturally tuned to use guanine contacts for substrate positioning. Relaxing guanine-specific contacts while manipulating residues at sites 1 through 3 may afford increased flexibility in allowing altered rotation of substrate ligands.
To identify the altered products generated by human cGAS R376I and T211Q/R376I enzymes, we first isolated and analyzed the products with high-resolution mass spectrometry. Mass spectrometry results confirm that the reprogrammed cGAS enzymes produce cyclic AMP-GMP, demonstrating that altered product migration by thin layer chromatography is not due to changes in base or chemical composition ( Figure 5B ). In agreement with reprogramming mutations resulting in a relaxed requirement for guanine-specific contacts, we also detect cdA by high-resolution mass spectrometry ( Figure 5B ), and the requirement for selecting the order of guanine incorporation is now reduced ( Figure S4 ). Importantly, the activity of reprogrammed cGAS enzymes retains the requirement for dsDNA stimulation ( Figure 5C ), indicating that reprogramming mutations that alter the active site properties do not change the overall enzyme function or ability to respond to DNA ligands.
Because mass spectrometry demonstrated that the engineered cGAS variants produce cyclic AMP-GMP, we reasoned that reduced product mobility is indeed caused by altered cyclic dinucleotide chemical linkage and reprogramming of the enzymatic activity away from a metazoan-specific 2ʹ-5ʹ linkage. To test this hypothesis, we conducted nuclease P1 digestions to intermediate ( Figure 5D ). In contrast to the WT enzyme, cGAS R376I and T211Q/R376I products gain sensitivity to nuclease P1, confirming that they contain 3-5ʹ linkages ( Figure 5D , right). Selective signaling of reprogrammed cGAS enzymes through only 3 0 -5 0 permissive STING alleles in cells provides further confirmation of 3ʹ-5ʹ cyclic dinucleotide production (see below). Collectively, these data provide support for our structural model of DncV and cGAS phosphodiester linkage control and demonstrate successful reprogramming of the human cGAS enzyme to produce 3ʹ-5ʹ linked dinucleotide products.
Active Site Plasticity Is Unique to Eukaryotic cGAS Enzymes
Because alterations to amino acids at sites 1 and 2 reprogrammed human cGAS to produce 3ʹ-5ʹ linked dinucleotide products, we tested the corresponding eukaryotic amino acids in Vibrio DncV to determine whether cGAS-like active site residues are sufficient for conversion to 2ʹ-5ʹ product formation. We cloned seven Vibrio DncV constructs with single, double, or triple human cGAS site 1, 2, and 3 substitutions and tested potential cyclic dinucleotide synthesis activity in cells using a STING-dependent IFN-b luciferase reporter assay. In contrast to human cGAS, DncV exhibited the opposite pattern of substitution tolerance, whereby mutation of site 1 to a recessed amino acid (Q113T) abolished all detectable cyclic dinucleotide production, and mutation of site 2 to an extended amino acid (I258R) did not impact enzymatic activity ( Figure S5 ). These results confirm a close relationship between ''extended'' and ''recessed'' amino acids at sites 1 and site 2 in both prokaryotic and eukaryotic cGAS-like enzymes where, in each case, the conserved extended amino acid plays a dominant role. The observation that site 1 mutations in DncV abolish all detectable activity suggests that enzyme active site plasticity leading to reprogramming is unique to eukaryotic cGAS enzymes ( Figure S5 ). These results demonstrate that modulation of a prokaryotic cGAS-like enzyme requires further alteration to the enzyme active site in addition to a eukaryotic combination of recessed/extended mutations at sites 1 and 2. Increased tolerance in the human cGAS active site may be a prerequisite stage in the evolution of the ability to catalyze two distinct phosphodiester bonds. It is possible that the unique ability of human cGAS to allow reprogramming to 3ʹ-5ʹ linkage specificity enables recreation of a more ancestral state of the enzyme; further characterization of ancestral cGAS-like homologs will be required to evaluate this conclusion. The ability to reprogram human cGAS to synthesize 3ʹ-5ʹ specific products will allow screening for additional mutations that increase activity and further modulate active site chemistry.
Reprogrammed Human cGAS Enzymes Signal Discrete
Alleles of the Adaptor STING We next tested the reprogrammed cGAS enzymes to determine their ability to signal within cells and promote innate immune activation. Previous studies have demonstrated that distinct human STING alleles exist and respond to different cyclic dinucleotide repertoires Diner et al., 2013; Jin et al., 2011) . Mouse STING responds to both 2ʹ-5ʹ cGAMP and canonically linked 3ʹ-5ʹ cGAMP, cdA, and cdG. In contrast, the human STING allele that encodes histidine at position 232 (R232H) responds only to 2ʹ-5ʹ cGAMP ( Figure 6A ) Diner et al., 2013) . In agreement with our in vitro results, both WT mSTING and hSTING R232H respond to the 2ʹ-5ʹ cGAMP product of WT cGAS enzyme, but only the mSTING WT allele responds to the product of reprogrammed cGAS enzymes, now producing 3ʹ-5ʹ linked cyclic dinucleotides ( Figure 6B ). Importantly, enzymatic reprogramming of the cGAS enzyme resulted in a signaling pattern similar to WT DncV, further verifying that the reprogrammed enzymes behave functionally as 3ʹ-5ʹ cyclic dinucleotide synthases, yet remain competent for cytosolic DNA recognition and triggering of the antiviral cascade. Because few mutations are required to alter cGAS product dinucleotide linkage specificity, it will be of interest to determine whether naturally occurring cGAS enzymatic variants also synthesize 3ʹ-5ʹ linked products. Endogenous signaling by 3ʹ-5ʹ linked cGAMP could help account for the existence of STING alleles with increased promiscuity in the human population (Jin et al., 2011) .
Conclusions
The results presented here show that DncV is both a structural and functional homolog of mammalian cGAS, demonstrating a A B Figure 6 . Reprogrammed Human cGAS Enzymes Signal Discrete Alleles of the Adaptor STING (A) In-cell reconstitution of cyclic dinucleotide immune activation. Cells were cotransfected with empty vector, human cGAS, or Vibrio DncV plasmids in the presence of WT mouse STING (mSTING WT) or the R232H allele of human STING incapable of responding to 3ʹ-5ʹ cGAMP (hSTING R232H). Activating dsDNA was cotransfected in all samples, and immune activation was monitored with a firefly luciferase reporter under control of the IFN-b promoter (pIFNb-FLuc).
(B) Cells were transfected as in A and included reprogrammed human cGAS enzymes as indicated. Data are normalized to the empty vector control, and error bars represent the SD from the mean of at least three independent experiments (the asterisk denotes p < 0.002, and n.s. denotes not significant). See also Figure S5 .
direct connection between the biosynthetic machinery for generating dinucleotide signals in multiple kingdoms of life. Our results provide evidence for an evolutionary relationship between prokaryotic and eukaryotic signaling systems and suggest an alternative to existing models hypothesizing that divergence within the ancestral metazoan immune repertoire led to creation of cGAS and OAS pathways separating cytosolic dsDNA and dsRNA recognition (Cai et al., 2014; Civril et al., 2013; Gao et al., 2013a; Kranzusch et al., 2013) . It will be of great interest to identify and compare further DncV and cGAS homologs to determine whether genetic exchange played a role in the development of cyclic dinucleotide signaling within mammalian innate immunity. Crystal structures of DncV in substrate bound and catalytically trapped linear-intermediate states explain why human cGAS produces the 2ʹ-5ʹ linked cGAMP that is unique to mammalian innate immunity. Rational redesign of the human cGAS active site to create enzymatic variants that synthesize 3ʹ-5ʹ linked species shows that relatively few mutations allow for specific signaling through alternative STING alleles. Our results reveal the potential existence of altered cGAS-signaling and demonstrate the enzymatic plasticity that allowed evolution of a unique metazoan innate immune molecule.
EXPERIMENTAL PROCEDURES Protein Purification
Vibrio cholerae DncV M4-L414 coding sequence (GenBank accession CP003069) was amplified by PCR and cloned into a custom pET vector optimized for E. coli expression of an N-terminal 6 3 His (KSSHHHHHHGSS)-MBP-TEV fusion protein (Kranzusch and Whelan, 2011) . Purification of DncV was adapted from a previously developed protocol optimized for full-length human cGAS, but for DncV, an ion-exchange step to remove bound nucleic acid was not required. Briefly, BL21-RIL DE3 E. coli cells were cotransformed with DncV expression vector and pRARE2 tRNA (Agilent) and grown in 2 3 YT media at 37 C to an OD 600 of $0.5. Cells were cooled at 4 C for 15 min, induced with 0.5 mM IPTG, and incubated with shaking at 16 C for $18 hr.
Cell pellets were washed with PBS, resuspended in lysis buffer (20 mM HEPES-KOH [pH 7.5], 400 mM NaCl, 10% glycerol, 30 mM imidazole, and 1 mM TCEP) supplemented with EDTA-free Complete Protease Inhibitor (Roche), and lysed by sonication. Clarified lysate was incubated with Ni-NTA agarose (QIAGEN) for 1 hr at 4 C, and recovered resin was washed with lysis buffer supplemented to 1 M NaCl by gravity-flow chromatography at 4 C.
Bound protein was eluted using lysis buffer supplemented to 300 mM imidazole, and MBP-tagged proteins were diluted to 50 mM imidazole and 5% glycerol and concentrated to $40 mg ml À1 prior to digestion with Tobacco Etch Virus protease for $15 hr at 4 C. Digested protein was diluted in gel filtration buffer (20 mM HEPES-KOH [pH 7.5], 250 mM KCl, and 1 mM TCEP) and passed over a 5 ml Ni-NTA column (QIAGEN) connected in line with a 5 ml MBP-Trap column (GE Life Sciences) to remove protease and digested MBP-tag. DncV protein was further purified by size-exclusion chromatography on a Superdex 75 16/60 column in gel-filtration buffer, and eluted protein was concentrated to 10-20 mg ml À1 . Purified protein was used immediately for crystallography or supplemented with 10% glycerol and flash frozen in liquid nitrogen and stored at À80 C for biochemical experiments. For preparation of selenomethionine-substituted DncV protein, cultures were grown in M9 minimal media supplemented with 1 mM MgSO 4 , 100 mM CaCl 2 , 1 mg ml À1 thiamine, 0.4% glucose, and trace elements. After growth at 37 C to an OD 600 of $0.4, cultures were supplemented with leucine, isoleucine, and valine at 50 mg l À1 ; phenylalanine, lysine, and threonine at 100 mg l À1 ; and selenomethionine (Acros Organics) at 75 mg l À1 . Cultures were grown at 37 C for an additional 30 min, cooled at 4 C for 15 min, induced with 0.5 mM IPTG, and incubated with shaking at 16 C for $18 hr. Selenomethionine-substituted protein was purified using identical conditions as native protein except buffers contained 2 mM TCEP. Full-length human cGAS was expressed and purified as previously described (Kranzusch et al., 2013) . cGAS mutants were generated by Pfu Ultra polymerase (Stratagene) and QuikChange PCR and initially purified as MBPtagged proteins prior to dialysis overnight at 4 C (20 mM HEPES-KOH 7.5, 150 mM KCl, 10% glycerol, and 1 mM TCEP). Dialyzed protein was concentrated and stored for biochemistry similar to purified DncV. cGAS R376I and T211Q/R376I enzymes were subsequently purified with MBP-tag removal as previously described (Kranzusch et al., 2013) .
Crystallization and Structure Determination
Crystals of DncV were grown at 18 C by hanging-drop vapor diffusion. Purified $10 mg ml À1 DncV protein was incubated on ice for 30 min with 5 mM NTP combinations and 10.5 mM MgCl 2 . Following incubation, Easy-Xtal 15-well trays (QIAGEN) were used to set 2 ml 1:1 or 0.8:1.2 (protein: reservoir) ratio drops over 350 ml of reservoir solution. Additionally, for some NTP conditions, crystallization was optimized by premixing protein-NTP and reservoir solutions and incubating at room temperature for 10 min prior to brief centrifugation and setting drops with mixture supernatant. Original crystallization conditions were determined by sparse-matrix screen using 400 nl drops set over 70 ml reservoir solutions in a 96-well format. Optimal crystallization conditions were 30 mM HEPES-KOH [pH 7.5], 200-300 mM Mg(OAc) 2 and 20-22% PEG-3350, but slight refinements to these conditions were required for growth with different substrates. Crystals grew as clusters of rods and required incubation at 18 C for 2-4 days for complete growth. Individual crystals were harvested by gently tweezing the nucleation center with a nylon loop or a Kozak cat whisker to release single rods. Crystals were transferred with a nylon loop to a new drop containing reservoir solution supplemented with 15%-20% ethylene glycol or glycerol as a cryoprotectant and incubated for 15 s before flash freezing in liquid nitrogen. Selenomethionine crystals were grown and harvested using similar conditions and optimized by micro or streak-seeding crushed native crystals with a Kozak cat whisker. Native and anomalous data were collected under cryogenic conditions at the Lawrence Berkeley National Laboratory Advanced Light Source (Beamline 8.3.1) and Stanford Synchotron Radiation Lightsource (Beamlines 11.1 and 12.2). X-ray diffraction data were processed with XDS and SCALA (Kabsch, 2010 ) using the SSRL autoxds script (A. Gonzalez, SSRL). Indexed crystals belonged to the orthorhombic space group P 2 1 with two copies of DncV in the asymmetric unit. For phase determination, a series of independent data sets was collected from a single large selenomethionine crystal using a microfocus beam at the peak selenium absorbance energy. These data sets were then merged to create a single high multiplicity data set, allowing selenium sites to be identified with HySS within PHENIX (Adams et al., 2010 ). An initial map was calculated using SOLVE/RESOLVE (Terwilliger, 1999) , providing interpretable electron density for de novo building of a mixed poly-alanine and native sequence model of one DncV monomer using Coot (Emsley and Cowtan, 2004 ). This partial structure was then used as a molecular replacement search model to extend phases into a 1.8 Å native pppA[3ʹ-5ʹ]pG data set. Iterative rounds of model building in Coot and refinement were conducted with PHENIX until all interpretable electron density was modeled. Data for refinement of the native pppA[3ʹ-5ʹ]pG structure were extended to 1.8 Å , 0.2 Å beyond an I/s resolution cutoff ($1.98 Å ) as determined by CC* correlation and R pim parameters (Karplus and Diederichs, 2012) . The completed DncV model was then used as a search model and reference restraint to build the remaining apo and substrate-bound structures.
In Vitro Reconstitution of Cyclic Dinucleotide Synthesis and Nucleic Acid Sensitivity DncV and cGAS cyclic dinucleotide synthesis was performed and measured as previously described (Kranzusch et al., 2013) . Briefly, $1 mM of purified enzyme or equivalent volume of gel-filtration buffer was incubated with $25 mM NTP substrates and $10 mCi radiolabeled [ (Stetson and Medzhitov, 2006) , and DncV reactions include 2 mM of indicated nucleic acids as previously described (Kranzusch et al., 2013) . Following incubation, 5 ml of the reaction volume were transferred to a new tube and treated with 5 units of alkaline phosphatase (NEB) at 37 C for 45 min to digest remaining unincorporated labeled NTPs. Reactions were terminated by spotting 1 ml onto a PEI-cellulose F thin-layer chromatography (TLC) plate (EMD Biosciences) and drying for 5 min at room temperature. TLC plates were developed with 1.5 M KH 2 PO 4 (pH 3.8) and run until $2 cm from the top edge of an $20 cm plate. Plates were dried at 80 C for 30 min, and radiolabeled products were detected with a phosphorscreen and Storm phosphorimager (GE Life Sciences). Where indicated, reactions were additionally digested with 2 mU of Nuclease P1 from Penicillium citrinum (Sigma) in 13 P1 buffer (30 mM NaOAc [pH 5.3], 0.4 mM ZnSO 4 ), following alkaline phosphatase treatment by incubating at 45 C for 30 min as previously described (Rahmeh et al., 2009) . DncV electrophoretic mobility shift assays were prepared with identical reaction conditions using nucleic acid substrates labeled at the 5ʹ end with T4 PNK (NEB) and [ɣ-32 P]-ATP as previously described and separated on a 6% nondenaturing polyacrylamide gel with 0.5% TBE at 6 W for 1.5 hr. Example images in figures are representative of multiple independent experiments.
cGAS R376I Product Purification and Structural Characterization
The enzymatic reaction products from cGAS R376I were purified as previously described using an Agilent HPLC with mixed components from the 1200 series and 1260 series (Diner et al., 2013) . Briefly, purification was performed using an Agilent Polaris C18-A column (4.6 3 250 mm, 5 mm). Purification conditions included a 100% to 0% gradient of solvent A over 20 min at 50 C and a flow rate of 1 ml min À1 ; solvent A was 100 mM ammonium acetate in water at pH 7, and solvent B was acetonitrile. Purified elution fractions were evaporated multiple times in order to remove excess ammonia. 
Cell-Based IFN-b Luciferase Assay
Full-length cDNA sequences for Vibrio DncV, human cGAS, human mutant STING (hSTING R232H), and WT mouse STING (mSTING WT) were cloned into pcDNA vectors (Invitrogen) for mammalian cell expression. 293T cells were seeded into opaque 96-well plates 20 hr prior to transfection at a density optimized to be 75%-80% confluent at the time of transfection. Cells were transfected as indicated along with a control Renilla luciferase reporter plasmid and an IFN-b promoter Firefly luciferase reporter plasmid as previously described (Inn et al., 2011; Kranzusch et al., 2013) . At 24 hr posttransfection, Firefly and Renilla luciferase values were measured using the Dual-Luciferase Reporter Assay System (Promega) and a Veritas Microplate Luminometer (Turner Biosystems) according to the manufacturer's protocols. IFN-b Firefly luciferase expression was normalized to transfection efficiency by calculating the relative expression of Firefly luciferase to Renilla luciferase activity. As indicated (Figure 6 ), data were combined from multiple independent experiments, and statistical significance was calculated with an unpaired, two-tailed t test in Prism.
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